Sinus dilation devices are the devices which are used to dilate and clear the blocked sinus during a sinus infection. Acute cases of sinus are often being treated with 1st line of therapy, while majority of chronic cases require surgical intervention. The global sinus dilation devices market is anticipated to grow with a CAGR of 7.98% during the forecast period, i.e., 2020-2028. The market is thriving on the back of the increasing incidences of chronic sinusitis (CNS) globally, coupled with the increasing number of product launch in the recent years and the increasing collaborations between companies for the research and development of new products. The global sinus dilation devices market is further projected to touch USD 3514 million by the end of 2028.
The global sinus dilation devices market is segmented by regions into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Among these regions, the North America sinus dilation devices market held the largest share of 28.7% in the year 2019 and is further projected to reach USD 1108 million by the end of 2028. Increasing prevalence of sinusitis in the region, coupled with the increasing investments for technological innovations, rising healthcare expenditure, along with the favorable initiatives of the government are some of the significant factors anticipated to drive the growth of the market in the region. The rising healthcare expenditure in the region is projected to accelerate the R&D activities, which may result in the development of advanced treatment modalities offering effective results. Additionally, the manufacturers in the region are also investing significantly to approve their products for the treatment of chronic sinusitis, which is further anticipated to drive the market growth in the region. According to the Centers for Disease Control and Prevention (CDC), in the United States, nearly 28.9 million adults were affected by sinusitis in 2018.
The study further incorporates Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). CLICK TO DOWNLOAD SAMPLE REPORT
The global sinus dilation devices market is segmented by patient type into adult and pediatric patients, out of which, the adult patient segment is anticipated to hold the largest market share owing to the rising prevalence of chronic rhinosinusitis in adults, which is known to cause nasal swelling, nasal polyps, allergies and others. Additionally, adults with asthma, cystic fibrosis, or other immune problems are expected to develop chronic rhinosinusitis more often than others, which is raising the need for advanced surgical procedures by utilizing sinus dilation devices.
The global sinus dilation devices market is segmented by product type into balloon sinuplasty devices and sinus stents/implants. Among these segments, the balloon sinuplasty devices segment is anticipated to hold the largest market share as these devices are highly preferred in the treatment of sinusitis. Balloon sinuplasty devices are used to dilate obstructed sinus ostia in patients suffering from chronic rhinosinusitis. Presently, these devices are being highly used in outpatient settings owing to the numerous benefits associated with the product, such as it doesn’t require the removal of a tissue or bone during the treatment process and causes less bleeding as compared to conventional treatment processes.
The global sinus dilation devices market is segmented by balloon diameter into less than 5mm, 5-10mm, and greater than 10mm. Among these segments, the less than 5mm segment is anticipated to register the largest market share owing to its increasing application in the pediatric patients’ maxillary sinus. Balloon sinuplasty devices are used in sinus surgeries to create a durable opening and enable the otolaryngologists to treat them effectively. With the increasing CRS incidents, sinus dilation devices are being increasingly used to dilate the maxillary sinus ostia for diagnostic and therapeutic purposes. The balloon's standard size in the balloon dilation sinuplasty procedure is usually 5 mm or less than that. Such factors are anticipated to drive the growth of the segment in the global sinus dilation devices market.
The global sinus dilation devices market is also segmented by procedure into standalone sinus dilation and hybrid sinus dilation. The standalone sinus dilation is a minimally invasive trans-nasal procedure that utilizes balloon technology to treat frontal, maxillary, or sphenoid sinus outflow obstruction. The hybrid sinus dilation procedure, on the other hand, deals with the balloon dilation and FESS for the treatment of patients with chronic rhinosinusitis. The global sinus dilation devices market is further segmented by end-user into hospitals, ambulatory surgical centers and ENT clinics. Among these segments, the hospital segment accounted for a significant market share owing to the rising number of sinus surgery procedures in these settings, coupled with the fact that the hospitals encounter a high patient influx as compared to other healthcare facilities.
The demand for minimally invasive surgeries over the past few years have grown significantly, backed by the recent innovations and advancements in instrumentation, along with the fewer complications and less pain associated with the surgery process. Minimally invasive surgical procedures are patient-friendly as it can be done in approximately 45-50 minutes. With the increasing prevalence for chronic sinusitis, the number of surgeries has also increased significantly. Patients suffering from chronic rhinosinusitis are currently being treated with minimally invasive sinus technique (MIST), such as balloon sinuplasty. Such factors are anticipated to drive the growth of the global sinus dilation devices market.
Sinusitis is an inflammation that commonly occurs in the lining of the sinuses and can be acute or chronic. Healthy sinuses are filled with air, but it can cause infection in an individual when they become blocked with fluid. Chronic sinusitis has become a common health problem worldwide, particularly in high atmospheric pollution levels. As a result, there is a rising need for sinus dilation devices, which is anticipated to drive the market growth. On the other hand, manufacturers across the world are highly focused on incorporating advanced technologies into the sinus dilation devices for the treatment of chronic rhinosinusitis. Emerging technologies such as flexible microsensor technology are anticipated to bring evolution to the current sinusitis treatment procedures. This technology provides real-time tracking of the balloon devices during the balloon sinus ostial dilation procedures. This technology has gained immense popularity as a highly effective minimally invasive procedure for the treatment of sinusitis, which is anticipated to drive the market growth during the forecast period.
While the demand for sinus dilation devices is increasing worldwide, influenced by the rapid increase in the occurrence of chronic sinusitis, certain factors are limiting the growth of the market worldwide. For instance, the risks associated with the procedures such as bleeding, postoperative infections, recurrent sinus infections, and others are some of the key factors anticipated to hamper the market growth.
The COVID-19 pandemic has led to the economic downfall of various countries across the world. Medical device manufacturers have witnessed various challenges in the past few months and as the burden continues to increase, the medical device manufacturers are finding it difficult to manage their products, supply chain, and regulatory obligations. Similar to drugs, medical devices rely heavily on healthcare facilities for their trial and data collection. Most medical devices undergo extensive trials, both pre- and post-market. As healthcare operators are currently focusing on to curb the spread of the pandemic, hence, it has been difficult for the players operating in the manufacturing of sinus dilation devices to continue with their clinical trials.
Some of the prominent industry leaders in the global sinus dilation devices market are Acclarent, Inc., Stryker, Medtronic, InnAccel Technologies Pvt. Ltd., Meril Life Sciences Pvt. Ltd., Dalent Medical, Smith & Nephew, Intersect ENT, Inc., Olympus America, and Coronado Medical.
FREQUENTLY ASKED QUESTIONS
Increasing prevalence of sinusitis and increasing preferences for minimally invasive surgical procedures are some of the major factors driving the market growth.
The market is anticipated to attain a CAGR of 7.98% over the forecast period, i.e., 2020-2028.
The major players in the market are Acclarent, Inc., Stryker, Medtronic, InnAccel Technologies Pvt. Ltd., Meril Life Sciences Pvt. Ltd., Dalent Medical, Smith & Nephew, and others.
The company profiles are selected based on the revenues generated from segments, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The sinus dilation devices market is segmented by patient type, product type, balloon diameter, procedure, end-user, and by region.
The adult patient segment, which is a sub-segment of the patient type segment, is anticipated to hold the largest market share owing to the rising prevalence of chronic rhinosinusitis in adults.
Concerns for the risks, such as bleeding, postoperative infections, recurrent sinus infections, and others, associated with the utilization of sinus dilation devices is one of the major factors estimated to act as barriers to the growth of the market.
Global Sinus Dilation Devices Market
Select License Type
Direct access to analyst to help you understand the market in a better way to handle your critical question
Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved
Get 10% free customization